Connecting proliferation and apoptosis in development and disease

Nature Reviews Molecular Cell Biology

Volumn 5, Issue 10, 2004, Pages 805-815

  Hipfner, David R ^a   Cohen, Stephen M ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN BCL 2;

APOPTOSIS; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; EMBRYO DEVELOPMENT; ONCOGENE MYC; PHOTORECEPTOR CELL; PIGMENT CELL; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; REVIEW; TISSUE GROWTH;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL DIVISION; DROSOPHILA PROTEINS; EMBRYO; GENES, P16; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 5044232018     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1491     Document Type: Review

References (136)

1. Edgar, B. A. & Orr-Weaver, T. L. Endoreplication cell cycles: more for less. Cell 106, 297-306 (2001).
2. Morata, G. & Ripoll, P. Minutes: mutants of Drosophila autonomously affecting cell division rate. Dev. Biol. 42, 211-221 (1975).
3. Grandori, C., Cowley, S. M., James, L. P. & Eisenman, R. N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653-699 (2000).
4. Pelengaris, S., Khan, M. & Evan, G. c-MYC: more than just a matter of life and death. Nature Rev. Cancer 2, 764-776 (2002).
5. Eisenman, R. N. Deconstructing myc. Genes Dev. 15, 2023-2030 (2001).
6. Levens, D. Disentangling the MYC web. Proc. Natl Acad. Sci. USA 9, 5757-5759 (2002).
7. Fernandez, P. C. et al. Genomic targets of the human c-Myc protein. Genes Dev. 17, 1115-1129 (2003).
8. Orian, A. et al. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 17, 1101-1114 (2003).
9. Zeller, K. I., Jegga, A. G., Aronow, B. J., O'Donnell, K. A. & Dang, C. V. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol. 4, R69 (2003).
10. Bouchard, C. et al. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev. 15, 2042-2047 (2001).
11. Hermeking, H. et al. Identification of CDK4 as a target of c-MYC. Proc. Natl Acad. Sci. USA 97, 2229-2234 (2000).
12. Kip1 binding to newly formed complexes. Oncogene 14, 2373-2381 (1997).
13. O'Connell, B. C. et al. A large scale genetic analysis of c-Myc-regulated gene expression patterns. J. Biol. Chem. 278, 12563-12573 (2003).
14. Sears, R., Ohtani, K. & Nevins, J. R. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol. Cell. Biol. 17, 5227-5235 (1997).
15. Johnston, L. A., Prober, D. A., Edgar, B. A., Eisenman, R. N. & Gallant, P. Drosophila myc regulates cellular growth during development. Cell 98, 779-790 (1999). First papers (see also reference 30) implicating the Myc oncogene in the control of cellular growth and size in animal development.
16. Prober, D. A. & Edgar, B. A. Ras1 promotes cellular growth in the Drosophila wing. Cell 100, 435-446 (2000).
17. Neufeld, T. P., de la Cruz, A. F., Johnston, L. A. & Edgar, B. A. Coordination of growth and cell division in the Drosophila wing. Cell 93, 1183-1193 (1998). Shows that, as in yeast, cell division and cellular growth are separable processes in higher eukaryotes, and that tissue size is not measured in terms of the number of cell divisions, but in terms of mass.
18. Geng, Y. et al. Cyclin E ablation in the mouse. Cell 114, 431-431 (2003).
19. CIP1 by c-Myc in overcoming transforming growth factor β-induced cell-cycle arrest. Proc. Natl Acad. Sci. USA 97, 9498-9503 (2000).
20. Coller, H. A. et al. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl Acad. Sci. USA 97, 3260-3265 (2000).
21. Kip1 cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20, 1688-1702 (2001).
22. INK4b expression by Myc through association with Miz-1. Nature Cell Biol. 3, 392-399 (2001).
23. Cip1 decreases survival and synergizes with MYC in mutine lymphomagenesis. EMBO J. 21, 3739-3748 (2002).
24. Kip1-deficient mice. Cell 85, 733-744 (1996).
25. Kip1. Cell 85, 721-732 (1996).
26. Kip1 display increased body see, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-720 (1996).
27. Schmid, P., Schulz, W. A. & Hameister, H. Dynamic expression pattern of the myc protooncogene in midgestation mouse embryos. Science 243, 226-229 (1989).
28. Davis, A. C., Wims, M., Spotts, G. D., Hann, S. R. & Bradley, A. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7, 671-682 (1993).
29. Trumpp, A. et al. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414, 768-773 (2001). Shows that mammalian c-MYC controls organ and body size by regulating cell numbers.
30. Gallant, P., Shiio, Y., Cheng, P. F., Parkhurst, S. M. & Eisenman, R. N. Myc and Max homologs in Drosophila. Science 274, 1523-1527 (1996).
31. Bourbon, H. M. et al. A P-insertion screen identifying novel X-linked essential genes in Drosophila. Mech. Dev. 110, 71-83 (2002).
32. de la Cova, C., Abrili, M., Bellosta, P., Gallant, P. & Johnston, L. A. Drosophila Myc regulates organ size by inducing cell competition. Cell 117, 107-116 (2004). Together with references 114 and 122, provides strong evidence that cell competition contributes significantly to the control of organ size.
33. Mateyak, M. K., Obaya, A. J., Adachi, S. & Sedivy, J. M. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8, 1039-1048 (1997).
34. Thomas, G. An encore for ribosome biogenesis in the control of cell proliferation. Nature Cell Biol. 2, E71-E72 (2000).
35. Conlon, I. & Raff, M. Differences in the way a mammalian cell and yeast cells coordinate cell growth and cell-cycle progression. J. Biol. 2, 7 (2003).
36. Lambertsson, A. The minute genes in Drosophila and their molecular functions. Adv. Genet. 38, 69-134 (1998).
37. Saucedo, L. J. & Edgar, B. A. Why size matters: altering cell size. Curr. Opin. Genet. Dev. 12, 565-571 (2002).
38. Reis, T. & Edgar, B. A. Negative regulation of dE2F1 by cydin-dependent kinases controls cell cycle timing. Cell 117, 253-264 (2004).
39. Askew, D. S., Ashmun, R. A., Simmons, B. C. & Cleveland, J. L. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6, 1915-1922 (1991).
40. Evan, G. I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128 (1992). References 39 and 40 report the striking finding that an oncogene induces apoptosis.
41. Harrington, E. A., Bennett, M. R., Fanidi, A. & Evan, G. I. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13, 3286-3295 (1994).
42. Pelengaris, S., Khan, M. & Evan, G. I. Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109, 321-334 (2002). Shows that complex angiogenic and invasive tumours can be generated by driving proliferation and blocking apoptosis, without the need for additional mutations.
43. Nilsson, J. A. & Cleveland, J. L. Myc pathways provoking cell suicide and cancer. Oncogene 22, 9007-9021 (2003).
44. Juin, P., Hueber, A. O., Littlewood, T. & Evan, G. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 13, 1367-1381 (1999).
45. L. Mol. Cell. Biol. 23, 7256-7270 (2003).
46. Iaccarino, I., Hancock, D., Evan, G. & Downward, J. c-Myc induces cytochrome c release in Rat1 fibroblasts by increasing outer mitochondrial membrane permeability in a Bid-dependent manner. Cell Death Differ. 10, 599-608 (2003).
47. L or Bcl-2 is bypassed during lymphomagenesis. Mol. Cell. Biol. 21, 5063-5070 (2001).
48. Eischen, C. M. et al. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Oncogene 20, 6983-6993 (2001).
49. Mitchell, K. O. et al. Bax is a transcriptional target and mediator of c-myc-induced apoptosis. Cancer Res. 60, 6318-6325 (2000).
50. Juin, P. et al. c-Myc functionally cooperates with Bax to induce apoptosis. Mol. Cell. Biol. 22, 6158-6169 (2002).
51. Morrish, F., Giedt, C. & Hockenbery, D. c-MYC apoptotic function is mediated by NRF-1 target genes. Genes Dev. 17, 240-255 (2003).
52. Hueber, A. O. et al. Requirement forthe CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278, 1305-1309 (1997).
53. Amanullah, A., Liebermann, D. A. & Huffman, B. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation. Oncogene 21, 1600-1610 (2002).
54. Klefstrom, J., Verschuren, E. W. & Evan, G. c-Myc augments the apoptotic activity of cytosolic death receptor signaling proteins by engaging the mitochondrial apoptotic pathway. J. Biol. Chem. 277, 43224-43232 (2002).
55. Vafa, O. et al. c-Myc can induce DMA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol. Cell 9, 1031-1044 (2002).
56. Tanaka, H. et al. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-κB activity that facilitates MnSOD-mediated ROS elimination. Mol. Cell 9, 1017-1029 (2002).
57. Green, D. R. & Evan, G. I. A matter of life and death. Cancer Cell 1, 19-30 (2002).
58. Evan, G. & Littlewood, T. A matter of life and cell death. Science 281, 1317-1322 (1998).
59. Schmitt, C. A., McCurrach, M. E., de Stanchina, E., Wallace-Brodeur, R. R. & Lowe, S. W. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13, 2670-2677 (1999).
60. Jacobs, J. J. et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13, 2678-2690 (1999).
61. Strasser, A., Harris, A. W., Bath, M. L. & Gory, S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348, 331-333 (1990).
62. Eischen, C. M., Roussel, M. F., Korsmeyer, S. J. & Cleveland, J. L. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated tymphomagenesis. Mol. Cell. Biol. 21, 7653-7662 (2001).
63. Blyth, K. et al. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene 10, 1717-1723 (1995).
64. Elson, A., Deng, C., Campos-Torres, J., Donehower, L. A. & Leder, P. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene 11, 181-190 (1995).
65. Russell, J. L. et al. ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol. Cell. Biol. 22, 1360-1368 (2002).
66. Eischen, C. M., Weber, J. D., Roussel. M. F., Sherr, C. J. & Cleveland, J. L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13, 2658-2669 (1999). Shows that induction of tumours by Myc in vivo selects for disruption of ARF-MDM2-p53 regulation.
67. Fridman, J. S. et al. Tumor promotion by Mdm2 splice variants unable to bind p53. Cancer Res. 63, 5703-5706 (2003).
68. Alt, J. R., Greiner, T. C., Cleveland, J. L. & Eischen, C. M. Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis. EMBO J. 22, 1442-1450 (2003).
69. Zindy, F. et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424-2433 (1998).
70. Zindy, F. et al. Art tumor suppressor promoter monitors latent oncogenic signals in vivo. Proc. Natl Acad. Sci. USA 100, 15930-15935 (2003).
71. Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37 (1996).
72. Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649-659 (1997).
73. Sogame, N., Kim, M. & Abrams, J. M. Drosophila p53 preserves genomic stability by regulating cell death. Proc. Natl Acad. Sci. USA 100, 4696-4701 (2003).
74. Korinek, V. et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genet. 19, 379-383 (1998).
75. Pinto, D., Gregorieff, A., Begthel, H. & Clevers, H. Canonical Wnt signals are essentials for homeostasis of the intestinal epithelium. Genes Dev. 17, 1709-1713 (2003).
76. van de Wetering, M. et al. The α-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241-250 (2002).
77. He, T. C. et al. Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512 (1998).
78. You, Z. et al. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J. Cell Biol. 157, 429-440 (2002).
79. Altieri, D. C. Validating survivin as a cancer therapeutic target. Nature Rev Cancer 3, 46-54 (2003).
80. Zhang, T. et al. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res. 61, 8664-8667 (2001).
81. Kim, P. J., Plescia, J., Clevers, H., Fearon, E. R. & Altieri, D. C. Survivin and molecular pathogenesis of colorectal cancer. Lancet 362, 205-209 (2003).
82. Hipfner, D. R. & Cohen, S. M. The Drosophila Sterile-20 kinase Slik controls cell proliferation and apoptosis during imaginal disc development. PLoS Biol. 1, 244-256 (2003).
83. Wu, S., Huang, J., Dong, J. & Pan, D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts, Cell 114, 445-456 (2003).
84. Udan, R. S., Kango-Singh, M., Nolo, R., Tao, C. & Halder, G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nature Cell Biol. 5, 914-920 (2003).
85. Pantalacci, S., Tapon, N. & Leopold, P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nature Cell Biol. 5, 921-927 (2003).
86. Harvey, K. F., Pfleger, C. M. & Hariharan, I. K. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114, 457-467 (2003). References 83-86 clearly show the close coordination of apoptosis and proliferation control in vivo through the characterization of a tumour-suppressor protein complex in flies that might be relevant to cancer.
87. Hipfner, D. R., Weigmann, K. & Cohen, S. M. The bantam gene regulates Drosophila growth. Genetics 161, 1527-1537 (2002)
88. Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B. & Cohen, S. M. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113, 25-36 (2003). Characterization of the first microRNA that controls growth and apoptosis.
89. Du, W., Xie, J. E. & Dyson, N. Ectopic expression of dE2F and dDP induces cell proliferation and death in the Drosophila eye. EMBO J. 15, 3684-3692 (1996).
90. Prober, D. A. & Edgar, B. A. Interactions between Ras1, dMyc, and dP13K signaling in the developing Drosophila wing. Genes Dev. 16, 2286-2299 (2002).
91. Sears, R., Leone, G., DeGregori, J. & Nevins, J. R. Ras enhances Myc protein stability. Mol. Cell 3, 169-179 (1999).
92. Bergmann, A., Agapite, J., McCall, K. & Steller, H. The Drosophila gene hid is a direct molecular target of Ras-dependent survival signaling. Cell 95, 331-341 (1998).
93. Kurada, P. & White, K. Ras promotes cell survival in Drosophila by downregulating hid expression. Cell 95, 319-329 (1998).
94. Alavi, A., Hood, J. D., Frausto, R., Stupack, D. G. & Cheresh, D. A. Role of Raf in vascular protection from distinct apoptotic stimuli. Science 301, 94-96 (2003).
95. Hindley, A. & Kolch, W. Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases. J. Cell Sci. 115, 1575-1581 (2002).
96. Huser, M. et al. MEK kinase activity is not necessary for Raf-1 function. EMBO J. 20, 1940-1951 (2001).
97. Yang, L. & Baker, N. E. Cell cycle withdrawal, progression, and cell survival regulation by EGFR and its effectors in the differentiating Drosophila eye. Dev. Cell 4, 359-369 (2003).
98. Raisin, S., Pantalacci, S., Breittmayer, J. P. & Leopold, P. A new genetic locus controlling growth and proliferation in Drosophila melanogaster. Genetics 164, 1015-1025 (2003).
99. Johnston, L. A. & Gallant, P. Control of growth and organ size in Drosophila. Bioessays 24, 54-64 (2002).
100. Oldham, S. & Hafen, E. Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control. Trends Cell Biol. 13, 79-85 (2003).
101. Datar, S. A., Jacobs, H. W., de la Cruz, A. F., Lehner, C. F. & Edgar, B. A. The Drosophila cyclin D-Cdk4 complex promotes cellular growth. EMBO J. 19, 4543-4554 (2000).
102. Meyer, C. A. et al. Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression, EMBO J. 19, 4533-4542 (2000).
103. Frei, C. & Edgar, B. A. Drosophila cyclin D/Cdk4 requires hif-1 prolyl hydroxylase to drive cell growth. Dev. Cell 6, 241-251 (2004).
104. Justice, R. W., Zilian, O., Woods, D. F., Noll, M. & Bryant, P. J. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 9, 534-546 (1995).
105. Kango-Singh, M. et al. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 129, 5719-5730 (2002).
106. Tapon, N. et al. Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110, 467-178 (2002).
107. Xu, T., Wang, W., Zhang, S., Stewart, R. A. & Yu, W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 121, 1053-1063 (1995).
108. Tamaskovic, R., Bichsel, S. J. & Hemmings, B. A. NDR family of AGC kinases-essential regulators of the cell cycle and morphogenesis. FEBS Lett. 546, 73-80 (2003).
109. Dan, I., Watanabe, N. M. & Kusumi, A. The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol. 11, 220-230 (2001).
110. Stewart, R. A., Li, D. M., Huang, H. & Xu, T. A genetic screen for modifiers of the lats tumor suppressor gene identifies C-terminal Src kinase as a regulator of cell proliferation in Drosophila. Oncogene 22, 6436-6444 (2003).
111. Cheung, W. L. et al. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113, 507-517 (2003).
112. Conlon, I. & Raff, M. Size control in animal development. Cell 96, 235-244 (1999).
113. Simpson, P. & Morata, G. Differential mitotic rates and patterns of growth in compartments in the Drosophila wing. Dev. Biol. 85, 299-308 (1981). Provides evidence that faster-dividing cells out compete those that divide more slowly in developing tissues. Sets the stage for much of the recent progress in understanding size control.
114. Moreno, E. & Basler, K. dMyc transforms cells into super-competitors. Cell 117, 117-129 (2004).
115. Burke, R. & Basler, K. Dpp receptors are autonomously required for cell proliferation in the entire developing Drosophila wing. Development 122, 2261-2269 (1996).
116. Martin-Castellanos, C. & Edgar, B. A. A characterization of the effects of Dpp signaling on cell growth and proliferation in the Drosophila wing. Development 129, 1003-1013 (2002).
117. Johnston, L. A. & Sanders, A. L. Wingless promotes cell survival but constrains growth during Drosophila wing development. Nature Cell Biol. 5, 827-833 (2003).
118. Giraldez, A. J. & Cohen, S. M. Wingless and Notch signaling provide cell survival cues and control cell proliferation during wing development. Development 130, 6533-6543 (2003).
119. Nellen, D., Burke, R., Struhl, G. & Basler, K. Direct and long-range action of a DPP morphogen gradient. Cell 85, 357-368 (1996).
120. Lecuit, T. et al. Two distinct mechanisms for long-range patterning by Decapentaplegic in the Drosophila wing. Nature 381, 387-393 (1996).
121. Adachi-Yamada, T., Fujimura-Kamada, K., Nishida, Y. & Matsumoto, K. Distortion of proximodistal information causes JNK-dependent apoptosis in Drosophila wing. Nature 400, 166-169 (1999).
122. Moreno, E., Basler, K. & Morata, G. Cells compete for decapentaplegic survival factor to prevent apoptosis in Drosophila wing development. Nature 416, 755-759 (2002). References 114 and 122 provide evidence that cells might compete for limiting levels of a survival ligand in vivo.
123. Duman-Scheel, M., Weng, L., Xin, S. & Du, W. Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E. Nature 417, 299-304 (2002).
124. Leevers, S. J., Weinkove, D., MacDougall, L. K., Hafen, E. & Waterfield, M. D. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 15, 6584-6594 (1996).
125. Milan, M., Campuzano, S. & Garcia-Bellido, A. Developmental parameters of cell death in the wing disc of Drosophila. Proc. Natl Acad. Sci. USA 94, 5691-5696 (1997).
126. Tao, W. et al. Human homologue of the Drosophiia melanogaster lats tumour suppressor modulates CDC2 activity. Nature Genet 21, 177-181 (1999).
127. St John, M. A. et al. Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nature Genet. 21, 182-186 (1999).
128. Hisaoka, M., Tanaka, A. & Hashimoto, H. Molecular alterations of h-warts/LATS1 tumor suppressor in human soft tissue sarcoma. Lab Invest 82, 1427-1435 (2002).
129. Sibilia, M. et al. The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 102, 211-220 (2000).
130. Li, Y., Hively, W. P. & Varmus, H. E. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 19, 1002-1009 (2000).
131. Oro, A. E. et al. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 276, 817-821 (1997).
132. Taipale, J. & Beachy, P. A. The Hedgehog and Wnt signalling pathways in cancer. Nature 411, 349-354 (2001).
133. Thayer, S. P. et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425, 851-856 (2003).
134. Berman, D. M. et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425, 846-851 (2003).
135. Sun, X., Mariani, F. V. & Martin, G. R. Functions of FGF signalling from the apical ectodermal ridge in limb development. Nature 418, 501-508 (2002).
136. Megason, S. G. & McMahon, A. P. A mitogen gradient of dorsal midline Wnts organizes growth in the CMS. Development 129, 2087-2098 (2002).